Skip to Main content Skip to Navigation
Journal articles

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.

Abstract : Kinases downstream of B-cell antigen receptor (BCR) represent attractive targets for therapy in non-Hodgkin lymphoma (NHL). As clinical responses vary, improved knowledge regarding activation and regulation of BCR signaling in individual patients is needed. Here, using phosphospecific flow cytometry to obtain malignant B-cell signaling profiles from 95 patients representing 4 types of NHL revealed a striking contrast between chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) tumors. Lymphoma cells from diffuse large B-cell lymphoma patients had high basal phosphorylation levels of most measured signaling nodes, whereas follicular lymphoma cells represented the opposite pattern with no or very low basal levels. MCL showed large interpatient variability in basal levels, and elevated levels for the phosphorylated forms of AKT, extracellular signal-regulated kinase, p38, STAT1, and STAT5 were associated with poor outcome. CLL tumors had elevated basal levels for the phosphorylated forms of BCR-signaling nodes (Src family tyrosine kinase, spleen tyrosine kinase [SYK], phospholipase Cgamma), but had low alpha-BCR-induced signaling. This contrasted MCL tumors, where alpha-BCR-induced signaling was variable, but significantly potentiated as compared with the other types. Overexpression of CD79B, combined with a gating strategy whereby signaling output was directly quantified per cell as a function of CD79B levels, confirmed a direct relationship between surface CD79B, immunoglobulin M (IgM), and IgM-induced signaling levels. Furthermore, alpha-BCR-induced signaling strength was variable across patient samples and correlated with BCR subunit CD79B expression, but was inversely correlated with susceptibility to Bruton tyrosine kinase (BTK) and SYK inhibitors in MCL. These individual differences in BCR levels and signaling might relate to differences in therapy responses to BCR-pathway inhibitors.
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01475956
Contributor : Xavier Chard-Hutchinson <>
Submitted on : Thursday, June 1, 2017 - 10:27:23 AM
Last modification on : Monday, November 18, 2019 - 1:15:21 PM
Long-term archiving on: : Wednesday, September 6, 2017 - 6:48:34 PM

Files

Myklebust et al. - 2016 - Dist...
Files produced by the author(s)

Prepublished online as Blood First Edition paper, 23 December 2016

Identifiers

Citation

June H. Myklebust, Joshua Brody, Holbrook E. Kohrt, Arne Kolstad, Debra K. Czerwinski, et al.. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.. Blood, American Society of Hematology, 2017, 129 (6), pp.759-770. ⟨10.1182/blood-2016-05-718494⟩. ⟨hal-01475956⟩

Share

Metrics

Record views

456

Files downloads

371